News
HealthDay on MSN9m
P2Y12 Inhibitor Monotherapy Beneficial for Patients Who Undergo PCIFor patients who undergo percutaneous coronary intervention (PCI) and discontinue dual antiplatelet therapy (DAPT), P2Y12 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback